Plasminogen Activator Inhibitors:阻害薬のグローバル市場2014(薬開発、治験動向)

調査会社DelveInsight社が発行したリサーチレポート(データ管理コード:DIMR2014562)
◆英語タイトル:Plasminogen Activator Inhibitors -Pipeline Insights, 2014
◆発行会社/調査会社:DelveInsight
◆商品コード:DIMR2014562
◆発行日:2014年版(※最新版はお問い合わせください)
◆調査対象地域:グローバル
◆産業分野:製薬
◆ページ数:25以上
◆レポート言語:英語
◆レポート形式:PDF
◆納品方式:Eメール
◆販売価格オプション(消費税別)
Single UserUSD1,250 ⇒換算¥136,250見積依頼/購入/質問フォーム
Site Price(同一国内共有可)USD2,500 ⇒換算¥272,500見積依頼/購入/質問フォーム
Enterprise Price(複数国内共有可)USD4,000 ⇒換算¥436,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
DelveInsight社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[Plasminogen Activator Inhibitors:阻害薬のグローバル市場2014(薬開発、治験動向)]についてメールでお問い合わせはこちら
*** レポート概要(サマリー)***

DelveInsight’s,“Plasminogen Activator Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report is to establish the understanding for all the pipeline drugs that fall under Plasminogen Activator Inhibitors. This report provides information on the therapeutic development based on the Plasminogen Activator Inhibitors dealing with mechanism of action, comparative analysis at various stages covering Filed, Phase III, Phase II, Phase I, IND filed, Preclinical, Discovery and unknown stages, therapeutics assessment by monotherapy and combination products and molecule type drug information. The report also covers the companies information involved in the therapeutic development of the products. It also has highlighted the discontinued and dormant products.
Data Sources

The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by DelveInsight team of industry experts.

Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Magazines, Trade associations, Books, Industry Portals, Industry Associations and access to available databases.
Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated mechanism of action.


• The report provides a snapshot of the global therapeutic landscape of Plasminogen Activator Inhibitors
• The report provides pipeline products under drug profile section which includes product description, MOA, licensors & collaborators, development partner and chemical information
• Coverage of the Plasminogen Activator Inhibitors pipeline on the basis of target, MOA, route of administration, technology involved and molecule type
• The report reviews key players involved in the therapeutics development for Plasminogen Activator Inhibitors and also provide company profiling
• The report also gives the information of dormant and discontinued pipeline projects
• Pipeline products coverage based on various stages of development ranging from preregistration till discovery and undisclosed stages
• Provides pipeline assessment by monotherapy and combination therapy products, stage of development and molecule type

• Complete MOA intelligence and complete understanding over therapeutics development for Plasminogen Activator Inhibitors
• Identify the relationship between the drugs and use it for target finding, drug repurposing, and precision medicine.
• Devise corrective measures for pipeline projects by understanding Plasminogen Activator Inhibitors pipeline depth and focus of Indication therapeutics
• Developing strategic initiatives to support your drug development activities.
• Optimize your portfolio and keep you in touch with the rapidly changing pharmaceutical markets, and make the best decisions for your business.
• Develop and design in licensing and out licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
• Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies
• Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline
• Gaining a Full Picture of the Competitive Landscape for Evidence based Decisions

*** レポート目次(コンテンツ)***

• Plasminogen Activator Inhibitors Overview
• Plasminogen Activator Inhibitors Disease Associated
• Plasminogen Activator Inhibitors Pipeline Therapeutics
• Plasminogen Activator Inhibitors Therapeutics under Development by Companies
• Plasminogen Activator Inhibitors Late Stage Products (Filed and Phase III)
• Comparative Analysis
• Plasminogen Activator Inhibitors Mid Clinical Stage Products (Phase II)
• Comparative Analysis
• Plasminogen Activator Inhibitors Early Clinical Stage Products (Phase I and IND Filed)
• Comparative Analysis
• Plasminogen Activator Inhibitors Discovery and Pre-Clinical Stage Products
• Comparative Analysis
• Drug Candidate Profiles
• Plasminogen Activator Inhibitors – Therapeutics Assessment
• Assessment by Monotherapy Products
• Assessment by Combination Products
• Assessment by Route of Administration
• Assessment by Molecule Type
• Plasminogen Activator Inhibitors – Discontinued Products
• Plasminogen Activator Inhibitors – Dormant Products
• Companies Involved in Therapeutics Development for Plasminogen Activator Inhibitors
• Appendix
• Methodology
• Contact Us
• Disclaimer

• Number of Products under Development for Plasminogen Activator Inhibitors by Therapy Area, 2014
• Number of Products under Development for Plasminogen Activator Inhibitors, 2014
• Number of Products under Development by Companies
• Comparative Analysis by Late Clinical Stage Products (Filed and Phase III), 2014
• Comparative Analysis Mid Clinical Stage Products (Phase II), 2014
• Comparative Analysis Early Clinical Stage Products (Phase I and IND Filed), 2014
• Comparative Analysis Discovery and Pre-Clinical Stage Products, 2014
• Drug Candidates Profiles
• Plasminogen Activator Inhibitors Assessment by Monotherapy Products
• Plasminogen Activator Inhibitors Assessment by Combination Products
• Plasminogen Activator Inhibitors Assessment by Route of Administration
• Plasminogen Activator Inhibitors Assessment by Stage and Route of Administration
• Plasminogen Activator Inhibitors Assessment by Molecule Type
• Plasminogen Activator Inhibitors Assessment by Stage and Molecule Type
• Plasminogen Activator Inhibitors Therapeutics – Discontinued Products
• Plasminogen Activator Inhibitors Therapeutics – Dormant Products
• Products under Development by Companies, 2014

• Number of Products under Development for Plasminogen Activator Inhibitors by Therapy Area, 2014
• Number of Products under Development for Plasminogen Activator Inhibitors, 2014
• Late Clinical Stage Products (Filed and Phase III), 2014
• Mid Clinical Stage Products (Phase II), 2014
• Early Clinical Stage Products (Phase I and IND Filed), 2014
• Discovery and Pre-Clinical Stage Products, 2014
• Plasminogen Activator Inhibitors Assessment by Monotherapy Products
• Plasminogen Activator Inhibitors Assessment by Combination Products
• Plasminogen Activator Inhibitors Assessment by Route of Administration
• Plasminogen Activator Inhibitors Assessment by Stage and Route of Administration
• Plasminogen Activator Inhibitors Assessment by Molecule Type
• Plasminogen Activator Inhibitors Assessment by Stage and Molecule Type

*** レポートのキーワード ***

薬剤、医薬品、製薬企業、試験、作用機序(MOA)、パイプライン、開発

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/


※おすすめ調査資料
  • パキスタンのアンチノック剤市場(~2019)
    The report Anti-Knock Preparation Market in Pakistan to 2019 - Market Size, Development, and Forecasts offers the most up-to-date industry data on the actual market situation, and future outlook for anti-knock preparations in Pakistan. The research includes historic data from 2008 to 2014 and foreca …
  • 合成生物学の世界市場:ツール(ゼノ核酸、シャーシ・オーガニズム、酵素等)、技術(遺伝子合成、バイオインフォマティクス、ナノ技術等)、用途分析
    The synthetic biology market is rapidly evolving, with various technological advancements that have resulted in a paradigm shift within the market. This has resulted in advanced production of synthetic genes and chassis to develop synthetic organisms from scratch. In 2013, the oligonucleotides segme …
  • Hotel Princesa Yaiza S.A. – 企業概要
    WMI's 'Hotel Princesa Yaiza S.A. - Company Capsule' is a crucial resource for industry executives and anyone looking to access key information about 'Hotel Princesa Yaiza S.A.'. WMI's 'Hotel Princesa Yaiza S.A. - Company Capsule' report utilizes a wide range of primary and secondary sources, which a …
  • デジタル出力変換の世界市場分析
    With a fact based approach, Future Market Insights has skilfully crafted a multi-client oriented research report titled “Digital Power Conversion Market: Global Industry Analysis (2012-2016) and Opportunity Assessment (2017-2027)”. The main motive of this research study is to highlight various marke …
  • 脂肪酸の世界市場2016
    Notes:Production, means the output of Fatty Acid Revenue, means the sales value of Fatty Acid This report studies Fatty Acid in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with capacity, production, price, …
  • 世界のイプロジオン市場2017
    Notes:Sales, means the sales volume of Iprodione Revenue, means the sales value of Iprodione This report studies sales (consumption) of Iprodione in Global market, especially in United States, China, Europe and Japan, focuses on top players in these regions/countries, with sales, price, revenue and …
  • 世界及び中国の2-(2-ヒドロキシエチル)ピリジン市場2016
    The 'Global and Chinese 2-(2-Hydroxyethyl)Pyridine Industry, 2016 Market Research Report' is a professional and in-depth study on the current state of the global 2-(2-Hydroxyethyl)Pyridine industry with a focus on the Chinese market. The report provides key statistics on the market status of the 2-( …
  • 中国のカルボン酸市場2015
    The China Carboxylic Acids Industry Report 2015 is a professional and in-depth study on the current state of the Carboxylic Acids industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Carboxylic Acids mar …
  • 世界のリバース型肩プロテーゼ市場2017
    Reverse Shoulder Prosthesis Report by Material, Application, and Geography – Global Forecast to 2021 is a professional and in-depth research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United St …
  • 研究施設建設市場レポート:スウェーデン
    This report is the result of Timetric’s extensive market research covering the research facilities construction industry in Sweden. It contains detailed historic and forecast market value data for the research facilities construction industry, including a breakdown of the data by construction activi …
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(DIMR2014562 )"Plasminogen Activator Inhibitors:阻害薬のグローバル市場2014(薬開発、治験動向)" (英文:Plasminogen Activator Inhibitors -Pipeline Insights, 2014)はDelveInsight社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※H&Iグローバルリサーチ(登録第5864124号)及びH&I(登録第5783645号)はH&Iグローバルリサーチ株式会社の商標です。